Zurueck zur Suche

Reporte zur Charge 929 PN

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 5 MN 2 CA 1 IL 1 CT 1 PA 1 NH 1

VAERS 2724116

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929 PN

moderat
Staat
FL
Alter
66,0
Geschlecht
F
Eingang
14.12.2023
Impfdatum
12.12.2023
Beginn
12.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthma Chills Condition aggravated Decreased appetite Dyspnoea Fatigue Headache Influenza virus test negative Nausea SARS-CoV-2 test negative Viral test

Symptomtext

About 11 hours after vaccine (9pm) felt tired and a bit queasy; about 11pm started having severe chill which lasted a few hours. Chills were accompanied by nausea. About 3 AM, I woke up to find my breathing labored. I used my rescue inhaler (Albuterol) which helped. I also had a severe headache from about 11 PM. Headache lasted through the next morning but breathing problems and chills had stopped. I have not been able to eat since about 6PM on Tuesday. Now, about 2 days later, all symptoms except fatigue have ended. I feel like I may be able to try a little bland food later today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
I called my PCP and was tested for Covid (negative), the flu (negative) and was tested for a groups of 16 virus strains now prevalent (results pending)
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma
Andere Medikamente
Lipitor, omeprazol, famontidine, advair, Singulair, yuvafem, vitamin D, Calcium
Allergien
Dicyclomine
Vorherige Impfungen
-

VAERS 2728388

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 929pn

mild
Staat
FL
Alter
78,0
Geschlecht
F
Eingang
28.12.2023
Impfdatum
12.12.2023
Beginn
18.12.2023
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Discomfort Erythema Pain Pain in extremity

Symptomtext

Patient reports pain and redness in her left arm. She report the discomfort is responsive to ibuprofen and topical benadryl. She can move her arm though she says it is very painful. The pain began 6 days after the vaccine and has persisted. Advised patient to contact physician and rule out any other problems like a blood clot or traumatic injury.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
not known
Allergien
codeine and morphine
Vorherige Impfungen
-

VAERS 2727820

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

mild
Staat
FL
Alter
64,0
Geschlecht
F
Eingang
27.12.2023
Impfdatum
20.12.2023
Beginn
01.12.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Chills Discomfort Feeling cold Injection site pain Nausea Neck pain Pain

Symptomtext

Nausea; Injection site soreness; Uncomfortable; Back Pain/body, neck and back aches; Neck Pain/body, neck and back aches; Body aches/body, neck and back aches; Chills; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 64-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 929PN, expiry date 29-MAR-2025) for prophylaxis. On 20-DEC-2023 10:40, the patient received Arexvy (left arm). In DEC-2023, an unknown time after receiving Arexvy, the patient experienced discomfort (Verbatim: Uncomfortable), back pain (Verbatim: Back Pain/body, neck and back aches), neck pain (Verbatim: Neck Pain/body, neck and back aches), general body pain (Verbatim: Body aches/body, neck and back aches) and chills (Verbatim: Chills). On 20-DEC-2023, the patient experienced injection site pain (Verbatim: Injection site soreness). On 21-DEC-2023 02:00, the patient experienced nausea (Verbatim: Nausea). The patient was treated with paracetamol (Tylenol). The outcome of the injection site pain, discomfort, back pain, neck pain, general body pain and chills were not resolved and the outcome of the nausea was resolved. It was unknown if the reporter considered the injection site pain, nausea, discomfort, back pain, neck pain, general body pain and chills to be related to Arexvy. It was unknown if the company considered the injection site pain, nausea, discomfort, back pain, neck pain, general body pain and chills to be related to Arexvy. Additional Information: GSK Receipt Date: 21-DEC-2023 The patient self-reported this case. The patient reported that the injection site got sore as the evening progressed and was still sore today (on reporting day). The patient also reported that she had chills last night from reporting starting around midnight, where she was so cold, she had to drink a warm drink to warm up, and was still cold on reporting day. The patient also reported she had body, neck and back aches that started around midnight last night from reporting, and she still had these aches on reporting day. The patient was very uncomfortable and having to use heat on her back. The patient also reported that she had nausea that started around 2:30 to 2 AM (15 hours 20 minutes after vaccination) on reporting day morning, but it was now gone. The patient reported that she took 1-Tylenol Rapid Release 500 mg tablet around 1 to 2 AM reporting day morning; and the patient took 2 more Tylenol Rapid Release 500 mg tablets reporting day morning (no specific time provided). The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2725902

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929pn

mild
Staat
FL
Alter
68,0
Geschlecht
F
Eingang
20.12.2023
Impfdatum
19.12.2023
Beginn
19.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Chills Injection site pain Lethargy

Symptomtext

In the several hours after vaccination I felt mild lethargy and minimal injection site soreness. However at 11 hours post vaccination I developed a rapid onset of SEVERE uncontrollable RIGORS and joint pain (posterior neck, left shoulder, spine, left knee and both hips. I had no fever, nausea/vomiting, rash or lip/tongue swelling. The rigors and joint pain were unrelenting until I took Motrin 400 mg after which they diminished after 30 minutes or so. (The rigors were so severe and rapid that I couldn't hold the bottle of Motrin without tablets flying out of the bottle onto the floor)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Atorvastatin 20 mg daily
Allergien
Nickel and poison ivy allergy Tramadol intolerance
Vorherige Impfungen
-

VAERS 2724649

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

mild
Staat
CA
Alter
73,0
Geschlecht
M
Eingang
15.12.2023
Impfdatum
04.12.2023
Beginn
04.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site pruritus

Symptomtext

Patient experienced itchiness, redness, and soreness at site of administration later the same night (12/4/2023) and was recommended by outside source of pharmacy/medical personnel to take oral Benadryl OTC to help alleviate persisting symptoms sometime a week later (12/11/23).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Hyperlipidemia, Malignant neoplasm of thyroid gland
Andere Medikamente
Simvastatin and Levothyroxine
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2723903

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

mild
Staat
MN
Alter
75,0
Geschlecht
F
Eingang
13.12.2023
Impfdatum
06.12.2023
Beginn
06.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Discomfort Injection site pain Peripheral swelling Pruritus Rash Rash erythematous Skin irritation

Symptomtext

Patient reports more pain than normal during the injection. She started feeling itching and she said she got some red bumps and swelling on her right arm. By Sunday 12/10/2023 she felt itching in her body, the area was irritating, and she felt uncomfortable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
She took some loratadine and is feeling better. She did not need to seek medical testing and treatment.
Aktuelle Erkrankungen
non
Vorgeschichte
Asthma
Andere Medikamente
Losartan, Xopenen, accu-chek
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2723159

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929pn

mild
Staat
FL
Alter
74,0
Geschlecht
F
Eingang
12.12.2023
Impfdatum
09.12.2023
Beginn
10.12.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site inflammation Pruritus

Symptomtext

Patient came in today to show me her arm. She stated that she had gotten the Arexvy vaccine on Saturday. The site looked red and inflamed, and purple bruising. She did confirm she is on blood thinners. I was concerned about local site infection and suggested she go to her primary for follow up as she may need an oral anti-biotic. She wanted a recommendation for OTC itching products. She purchased topical hydrocortisone, topical Benadryl, and Claritin. She stated she was going to an urgent care after our discussion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
not sure
Vorgeschichte
not sure
Andere Medikamente
Not sure as patient does not have a prescription history with us.
Allergien
Azithromycin, cefaclor, ciprofloxacin, codeine, oxycodone, and penicillin all reported on 07/29/2011
Vorherige Impfungen
-

VAERS 2720408

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

mild
Staat
IL
Alter
67,0
Geschlecht
F
Eingang
03.12.2023
Impfdatum
30.11.2023
Beginn
30.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity Peripheral swelling Skin warm

Symptomtext

pt states she has arm pain, swelling, arm is hot since she was administered the immunization. Pt has use IBU/tylenol

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2717012

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

mild
Staat
CT
Alter
69,0
Geschlecht
F
Eingang
22.11.2023
Impfdatum
13.11.2023
Beginn
15.11.2023
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Injection site pain Skin warm

Symptomtext

Patient experienced erythema > 100mm along the left arm which was warm to the touch. Erythema first appeared approximately 16 hours after receiving vaccinations, with pain at injection site still present 2 days later, but improving from previous day

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2724577

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

gering
Staat
MN
Alter
-
Geschlecht
F
Eingang
15.12.2023
Impfdatum
21.11.2023
Beginn
21.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure via eye contact Exposure via skin contact Occupational exposure to product

Symptomtext

while mixing the diluent into the syringe she punctured the powder vial it blew up everywhere on her face and eyes; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of occupational exposure while preparing product for administration in a female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 929PN, expiry date 29-MAR-2025) for prophylaxis. This case was associated with a product complaint. On 21-NOV-2023, the patient received Arexvy. On 21-NOV-2023, an unknown time after receiving Arexvy, the patient experienced occupational exposure while preparing product for administration (Verbatim: while mixing the diluent into the syringe she punctured the powder vial it blew up everywhere on her face and eyes). The outcome of the occupational exposure while preparing product for administration was unknown. Additional Information: GSK receipt date:04-DEC-2023 The reporter reported that at the time of mixing the diluent into syringe the syringe was punctured the powder vial it blew up everywhere on the face and eyes, which led to occupational exposure while preparing product for administration. The reporter stated that it seems like a pressure issue or could be a faulty syringe. She was rinsed her eyes and she was fine after incident. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure via eye contact
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2723370

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929PN

gering
Staat
PA
Alter
89,0
Geschlecht
F
Eingang
12.12.2023
Impfdatum
04.12.2023
Beginn
05.12.2023
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia

Symptomtext

patient felt generalized weakness after the vaccine, patient advised to follow up with PCP if it doesn't subside

Weitere VAERSDATA-Felder
Praegender Schweregrund
Asthenia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2720566

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 929pn

gering
Staat
NH
Alter
64,0
Geschlecht
F
Eingang
04.12.2023
Impfdatum
04.12.2023
Beginn
04.12.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Throat tightness

Symptomtext

Pt left the pharmacy after receiving the vaccine. She came back a few minutes later saying that she was having a reaction to the vaccine. I asked her to sit down and breath. I asked her what reaction she was having and she said that she felt "pressure here", pointing at her trachea. She also said "I feel like I wont be able to breath". I said I was going to call 911 and the gentleman with her said "before you do that, I'm a physician, do you have a blood pressure cuff"?. A few minutes later they decided to go to the ER

Weitere VAERSDATA-Felder
Praegender Schweregrund
Throat tightness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-